[{"id":"46916f3b-5fbd-4c36-80c3-e0c13441714b","acronym":"","url":"https://clinicaltrials.gov/study/NCT05879458","created_at":"2023-05-30T14:05:08.419Z","updated_at":"2024-07-02T16:35:05.459Z","phase":"Phase 2","brief_title":"Ritlecitinib in CTCL","source_id_and_acronym":"NCT05879458","lead_sponsor":"Icahn School of Medicine at Mount Sinai","biomarkers":" TNFRSF8","pipe":" | ","alterations":" TNFRSF8 positive","tags":["TNFRSF8"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TNFRSF8 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Litfulo (ritlecitinib)"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 05/17/2023","start_date":" 05/17/2023","primary_txt":" Primary completion: 04/01/2026","primary_completion_date":" 04/01/2026","study_txt":" Completion: 04/01/2026","study_completion_date":" 04/01/2026","last_update_posted":"2024-05-07"}]